Combination of PIO with GLP-1R agonists The possible role of exenatide (EXE) and PIO combination therapy on hepatic fat content was investigated in 21 patients with T2D being on diet ( n = 4) and/or MET therapy for at least 3 months ( n = 17) [124]
To report any sale or distribution of unregistered food products and supplements, kindly email us at [email protected]
After significant weight loss, patients commonly develop: Loose abdominal skin Stretch marks Lower abdominal overhang Muscle separation (diastasis recti) Persistent skin laxity No medication can tighten stretched abdominal skin or repair separated abdominal muscles
Mechanistically, GLP1RAs improve cardiac function by enhancing contractility and reducing myocardial injury 14,15,16 , exert vasodilatory and endothelial-protective effects, and display anti-inflammatory and anti-fibrotic actions that may limit adverse remodeling in heart failure (HF) 17
Bhargava R, Chandra M, Bansal U, Singh D, Ranjan S, Sharma S